A New Solid-phase Immunoradiometric Assay for Anti-thyroglobulin Autoantibody
Overview
Authors
Affiliations
A newly developed sensitive and quantitative immunoradiometric assay (IRMA) for anti-thyroglobulin (anti-Tg) autoantibody is described. Serum samples to be tested are added to wells of polyvinyl microtiter plates coated with human thyroglobulin. After removal of the unbound material, anti-Tg antibody is determined by adding purified 125I-anti-human immunoglobulin G antibody. Using 1.0 microliter of serum anti-Tg antibody was detected in 81.2% of patients with Hashimoto's thyroiditis or idiopathic myxedema (n = 32), in 46.4% of those with Graves' disease (n = 28), in 11.9% of subjects with other thyroid disorders (n = 42) and in 4.2% of normal controls (n = 71). Similar percentages of positive tests were observed by passive hemagglutination (PH) and a good correlation was found between the antibody levels determined by the two techniques. Using larger amounts of serum (100 microliters) detectable anti-Tg antibody by IRMA was found in the majority of patients with thyroid autoimmune disorders who had negative PH tests. Quantitative measurements of anti-Tg antibody by IRMA could be obtained by using purified anti-Tg antibody as standard reference. The minimum detectable amount of anti-Tg antibody was 0.5 ng. The present method is proposed as a simple and convenient technique for quantitative measurement of any antibody, using wells coated with the appropriate antigen.
Katahira M, Tsunekawa T, Mizoguchi A, Yamaguchi M, Tsuru K, Takashima H Hormones (Athens). 2023; 22(2):253-261.
PMID: 36811756 DOI: 10.1007/s42000-023-00437-7.
Zhang J, Gao Y, Li Y, Teng D, Xue Y, Yan L Front Endocrinol (Lausanne). 2020; 11:139.
PMID: 32256451 PMC: 7093715. DOI: 10.3389/fendo.2020.00139.
Erdogan M, Erdem N, Cetinkalp S, Ozgen A, Saygili F, Yilmaz C Endocrine. 2009; 36(3):486-90.
PMID: 19856136 DOI: 10.1007/s12020-009-9258-z.
Graves' ophthalmopathy: state of the art and perspectives.
Bartalena L, Wiersinga W, Pinchera A J Endocrinol Invest. 2004; 27(3):295-301.
PMID: 15165007 DOI: 10.1007/BF03345280.
Marino M, Chiovato L, Lisi S, Altea M, Marcocci C, Pinchera A J Endocrinol Invest. 2004; 27(3):230-6.
PMID: 15164998 DOI: 10.1007/BF03345271.